This week’s Built With Biology Digest is brought to you by Leaps by Bayer.
Hi ,
We trust this finds you well and enjoying the fall season
(here in the Northern Hemisphere), as crisp, cool temperatures and changing foliage mark the advent of a nearing holiday season.
As many of you already know, the United Nations Climate Change Summit (COP26) slated for October 31 - November 12 in Glasgow, Scotland, will address much more severe climate change. We at SynBioBeta are hopeful that nations from around the world will roll up their proverbial sleeves, putting actions behind their words in efforts to slow (and eventually remedy) the precipitous slide into further global warming.
SynBioBeta applauds all forward-thinking companies taking action to address climate change. We encourage you to read (and share) the article below on the outstanding work Leaps by Bayer is doing in conjunction with The New York Times, as we believe you will greatly benefit from these highly engaging and informative video pieces.
Thank you for your kind attention and continued support.
Larry
|
 |
Larry Upton
Editor in Chief
larry.upton@synbiobeta.com
|
|
|
|
How Science Will Actually Solve Climate Change |
 |
If our planet gets 2 degrees Celsius (3.6 degrees Fahrenheit) warmer, all coral reefs will die, while flooding, droughts, extreme heat waves, and storms will become extreme on a global scale. At this year’s UN Climate Change Conference of the Parties (COP26) summit, world leaders have gathered to discuss climate change and take urgent action.
|
Keep Reading »
|
Spotlight on: Felix Biotechnology |
 |
Credit: Victor Padilla-Sanchez, The Catholic University of America.
Every year, antibiotic-resistant bacteria kill as many people as car crashes. Yet very few new, small molecule antibiotics have been developed in the last 30 years. We need a new way to combat these superbugs. Meet Felix Biotechnology, the company using bacteria’s ancient foes—viruses called bacteriophage or phage—as a new weapon to fight drug-resistant infections. Felix is building a phage engineering platform to develop novel therapies to tackle some of the toughest infections, starting with Pseudomonas, a family of bacteria that causes severe lung infections in people with cystic fibrosis. But, antibiotic resistance can affect anyone, so these therapies will benefit everyone. Keep up with Felix as the company fights back against more bacteria!
|
|
|
Spotlight on: bitBiome |
 |
Microbes are one of the world’s biggest, untapped resources. Their genetic functions are critical for developing new medicines and climate change solutions. But which of Earth’s estimated 1 trillion microbe species are useful and for what purpose? Meet bitBiome, the company accelerating the discovery of new microbial functions by rapidly sequencing their genomes. With its single-cell genome sequencing technology, the company is able to discover 10x more genes—and 10x more potential solutions—than traditional metagenomic methods. Want to know what each microbe in the soil, the ocean, or even your gut can do? Keep up with bitBiome to get all your questions answered!
|
|
|
|
|
|
|
 |
How Checkerspot Is Biomanufacturing Better Materials For A Post-Petroleum Future |
Checkerspot, a materials innovation company, is rethinking products from a molecular level. It is optimizing microbes to biomanufacture unique structural oils found in nature.
|
Keep Reading »
|
|
 |
The SynBio Innovation Accelerator, a Collaboration Between Codexis and Casdin Capital, Enables $10 million Investment in Molecular Assemblies |
Funding to accelerate Molecular Assemblies’s go-to-market strategy as the enzyme engineering phase nears completion.
|
Keep Reading »
|
|
|
 |
bit.bio Raises in Excess of $100 Million in First Close of Series B Financing |
Funding will accelerate clinical development of cell therapies using breakthrough gene engineering technology.
|
Keep Reading »
|
|
 |
Joyn Bio Announces Opening of New Facility to Develop Engineered Microbes for Crop Protection |
New greenhouse is custom built to enable the screening and discovery of engineered microbial strains that protect against diseases and pests of row and vegetable crops.
|
Keep Reading »
|
|
|
 |
Chemicals & Materials Digital Conference
|
November 17th, 2021
|
How do we build a sustainable world? Most of what we rely on in our daily lives, from our clothes to our homes, cars, medicines, tools, even the screen you’re reading this on right now, are made from unsustainable sources generating tons (literally) of carbon emissions. But what if we could build our modern world with biology instead?
|
Learn more »
|
|
|
|
|
|
|
Cambridge gene-editing startup Arbor Biotechnologies raises $215 million
|
Keep Reading »
|
|
|
An E. coli biocomputer solves a maze by sharing the work
|
Keep Reading »
|
|
|
Amyris announces JV partnership with ImmunityBio for next generation COVID-19 RNA vaccine
|
Keep Reading »
|
|
|
DNA Script to develop next generation of enzymatic DNA synthesis printers with $2.2 million grant
|
Keep Reading
»
|
|
|
|
|
Synlogic and Ginkgo Bioworks announce investigational synthetic biotic medicine for the treatment of homocystinuria
|
Keep Reading »
|
|
|
George Church lab spinout raises $25M for protein therapeutics
|
Keep Reading »
|
|
|
GenScript embraces automation at its first cell, gene therapy manufacturing US site
|
Keep Reading »
|
|
|
Brightseed receives grant to discover plant-based bioactives that can improve birth outcomes
|
Keep
Reading »
|
|
|
| We've Got More » |
WHO'S HIRING?
|
|
Bioinformatics Software Engineer, Inscripta, Pleasanton, CA or Boulder, CO
Senior Bioinformatics Software Engineer, Inscripta, Pleasanton, CA
Scientist/ Senior Scientist, Inscripta, Pleasanton, CA
Scientist – Synthetic DNA Production, Upstream Process, Generation Bio, Cambridge, MA
Business Development Director, Calyxt, Remote Worker
VP, Process Chemistry & Manufacturing, Calyxt, Remote Worker
Synthetic Biologist, Robigo, Cambridge, MA
SynBio Fungal Scientist, Allonnia, Boston, MA
Environmental Microbiologist, Allonnia, Boston, MA
Scientist II, Automated Strain Engineering, IFF, Palo Alto, CA
Field Applications Scientist (FAS): Inscripta – Europe
|
| Access The Job Board » |
|
|
